- Home
- KFY vs CPRX Comparison
KFY vs CPRX Comparison
Compare KFY & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KFY | CPRX |
|---|---|---|
| Founded | 1969 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.4B |
| IPO Year | 1998 | 2006 |
Fundamental Metrics
Financial Performance| Metric | KFY | CPRX |
|---|---|---|
| Price | $72.28 | $31.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $73.00 | $35.00 |
| AVG Volume (30 Days) | 333.6K | ★ 3.0M |
| Earning Date | 06-17-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.90% | N/A |
| EPS Growth | ★ 42.41 | 28.24 |
| EPS | ★ 3.84 | 0.50 |
| Revenue | ★ $1,819,519,000.00 | $119,072,803.00 |
| Revenue This Year | $6.92 | $9.20 |
| Revenue Next Year | $3.25 | $10.51 |
| P/E Ratio | ★ $18.29 | $62.55 |
| Revenue Growth | 12.20 | ★ 16.39 |
| 52 Week Low | $58.27 | $19.05 |
| 52 Week High | $78.50 | $32.56 |
Technical Indicators
Market Signals| Indicator | KFY | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 74.61 | 72.56 |
| Support Level | $71.89 | $31.00 |
| Resistance Level | $73.25 | $31.33 |
| Average True Range (ATR) | 1.84 | 0.08 |
| MACD | 0.56 | -0.20 |
| Stochastic Oscillator | 99.85 | 79.17 |
Price Performance
Historical ComparisonAbout KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.